Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.53 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | CCNC | P24863 | 1/20 | 0.47 |
| ▸ | CDK8 | P49336 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15429530 | 0.87 | CHRNB2 (0.50) | KMT2ACHRNB2CHRNA4 | |
| SCHEMBL30178403 | 0.84 | TBXAS1 (0.56) | KMT2ACHRNB2CHRNA4TSHRFAAH | |
| SCHEMBL171896 | 0.82 | CHRNB2 (0.68) | KMT2ACHRNB2CHRNA4TSHRMAPK1 | |
| SCHEMBL30338591 | 0.82 | CHRNB2 (0.68) | KMT2ACHRNB2CHRNA4TSHRMAPK1 | |
| SCHEMBL11034681 | 0.82 | TBXAS1 (0.60) | KMT2ACHRNB2CHRNA4NPC1LMNA | |
| SCHEMBL12480735 | 0.82 | TBXAS1 (0.60) | KMT2ACHRNB2CHRNA4NPC1LMNA | |
| SCHEMBL6253085 | 0.81 | CHRNB2 (0.58) | KMT2ACHRNB2CHRNA4TSHRFAAH | |
| SCHEMBL16673237 | 0.81 | ALDH1A1 (0.58) | KMT2ALMNACYP1A2CYP2C9CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL7207615 | 0.81 | CHRNB2 (0.66) | KMT2ACHRNB2CHRNA4TSHRMAPK1 | |
| SCHEMBL15429528 | 0.80 | CHRNB2 (0.56) | KMT2ACHRNB2CHRNA4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115070-B2 | Process for preparing acrylic acid from ethylene oxide and carbon monoxide | BASF SE (DE) | 2015-08-25 | — | — | US | disclosed |
| US-20140018570-A1 | PROCESS FOR PREPARING ACRYLIC ACID FROM ETHYLENE OXIDE AND CARBON MONOXIDE | BASF SE (DE) | 2014-01-16 | — | — | US | disclosed |
| US-20140018574-A1 | PROCESS FOR PREPARING ACRYLIC ACID BY A THERMOLYSIS OF POLY-3-HYDROXYPROPIONATE CATALYZED BY AT LEAST ONE MOLECULAR ACTIVE COMPOUND | BASF SE (DE) | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018570-A1 | PROCESS FOR PREPARING ACRYLIC ACID FROM ETHYLENE OXIDE AND CARBON MONOXIDE | HPD, HAAO, HAO2 | KMT2A 2773/4885CHRNB2 2148/4885CHRNA4 1949/4885 |
| US-20140018574-A1 | PROCESS FOR PREPARING ACRYLIC ACID BY A THERMOLYSIS OF POLY-3-HYDROXYPROPIONATE CATALYZED BY AT LEAST ONE MOLECULAR ACTIVE COMPOUND | HPD, HAAO, GRHPR | KMT2A 1819/4885CHRNB2 3696/4885CHRNA4 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.